Cargando…
Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders
Chaperone Mediated Autophagy (CMA) is a lysosomal-dependent protein degradation pathway. At least 30% of cytosolic proteins can be degraded by this process. The two major protein players of CMA are LAMP-2A and HSC70. While LAMP-2A works as a receptor for protein substrates at the lysosomal membrane,...
Autores principales: | Alfaro, Iván E., Albornoz, Amelina, Molina, Alfredo, Moreno, José, Cordero, Karina, Criollo, Alfredo, Budini, Mauricio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365421/ https://www.ncbi.nlm.nih.gov/pubmed/30766511 http://dx.doi.org/10.3389/fendo.2018.00778 |
Ejemplares similares
-
Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
por: Ormeño, Fernando, et al.
Publicado: (2020) -
Chaperone Mediated Autophagy Substrates and Components in Cancer
por: Rios, Javiera, et al.
Publicado: (2021) -
Palmitic and Stearic Acids Inhibit Chaperone-Mediated Autophagy (CMA) in POMC-like Neurons In Vitro
por: Espinosa, Rodrigo, et al.
Publicado: (2022) -
Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
por: Budini, Mauricio, et al.
Publicado: (2017) -
Autophagy in aging-related oral diseases
por: Peña-Oyarzún, Daniel, et al.
Publicado: (2022)